Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tepper

Showing results (421-430 of 432) with videos related to

Pageof 44
Sort By:
Cephalalgia : an International Journal of Headache|May 16, 2026
Benefits of eptinezumab on patient-reported disease burden and health-related quality of life in adults with chronic migraine and medication-overuse headache: Results from the placebo-controlled RESOLUTION trialStewart J Tepper, Henrik W Schytz, Rigmor H Jensen, et al.
The Journal of Headache and Pain|June 13, 2026
Efficacy and safety of eptinezumab in adults with chronic migraine and medication-overuse headache who also received patient education: 24-week results of the randomized RESOLUTION trialHenrik W Schytz, Rigmor H Jensen, Christofer Lundqvist, et al.
JAMA Neurology|September 16, 2024
Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine: A Phase 4, Randomized, Placebo-Controlled TrialStewart J Tepper, David W Dodick, Michel Lanteri-Minet, et al.
Headache|November 23, 2019
The American Registry for Migraine Research: Research Methods and Baseline Data for an Initial Patient CohortTodd J Schwedt, Kathleen Digre, Stewart J Tepper, et al.
European Journal of Neurology|August 21, 2025
Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache: Final Results From a Phase 4 Randomized Placebo-Controlled StudyStewart J Tepper, David W Dodick, Michel Lanteri-Minet, et al.
Cephalalgia : an International Journal of Headache|March 6, 2018
A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study)Amaal J Starling, Stewart J Tepper, Michael J Marmura, et al.
Cephalalgia : an International Journal of Headache|June 16, 2004
LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraineC N Sang, N M Ramadan, R G Wallihan, et al.
The Journal of Headache and Pain|March 4, 2026
Correction: Diagnosis challenges and accessibility barriers to migraine management in Southeast Asia: results from the South-East Asia Local breAch on MigraiNe Treatment (SEALANT) studyWanakorn Rattanawong, Akarin Hiransuthikul, Prakit Anukoolwittaya, et al.
The Journal of Headache and Pain|February 17, 2026
Diagnosis challenges and accessibility barriers to migraine management in Southeast Asia: results from the South-East Asia Local breAch on MigraiNe Treatment (SEALANT) studyWanakorn Rattanawong, Akarin Hiransuthikul, Prakit Anukoolwittaya, et al.
Cephalalgia : an International Journal of Headache|October 21, 2022
Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster HeadacheJean Schoenen, Agneta Henriette Snoer, Roemer B Brandt, et al.
Pageof 44

Showing results (421-430 of 432) with videos related to

Sort By:
Pageof 44
Cephalalgia : an International Journal of Headache|May 16, 2026
Benefits of eptinezumab on patient-reported disease burden and health-related quality of life in adults with chronic migraine and medication-overuse headache: Results from the placebo-controlled RESOLUTION trialStewart J Tepper, Henrik W Schytz, Rigmor H Jensen, et al.
The Journal of Headache and Pain|June 13, 2026
Efficacy and safety of eptinezumab in adults with chronic migraine and medication-overuse headache who also received patient education: 24-week results of the randomized RESOLUTION trialHenrik W Schytz, Rigmor H Jensen, Christofer Lundqvist, et al.
JAMA Neurology|September 16, 2024
Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine: A Phase 4, Randomized, Placebo-Controlled TrialStewart J Tepper, David W Dodick, Michel Lanteri-Minet, et al.
Headache|November 23, 2019
The American Registry for Migraine Research: Research Methods and Baseline Data for an Initial Patient CohortTodd J Schwedt, Kathleen Digre, Stewart J Tepper, et al.
European Journal of Neurology|August 21, 2025
Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache: Final Results From a Phase 4 Randomized Placebo-Controlled StudyStewart J Tepper, David W Dodick, Michel Lanteri-Minet, et al.
Cephalalgia : an International Journal of Headache|March 6, 2018
A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study)Amaal J Starling, Stewart J Tepper, Michael J Marmura, et al.
Cephalalgia : an International Journal of Headache|June 16, 2004
LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraineC N Sang, N M Ramadan, R G Wallihan, et al.
The Journal of Headache and Pain|March 4, 2026
Correction: Diagnosis challenges and accessibility barriers to migraine management in Southeast Asia: results from the South-East Asia Local breAch on MigraiNe Treatment (SEALANT) studyWanakorn Rattanawong, Akarin Hiransuthikul, Prakit Anukoolwittaya, et al.
The Journal of Headache and Pain|February 17, 2026
Diagnosis challenges and accessibility barriers to migraine management in Southeast Asia: results from the South-East Asia Local breAch on MigraiNe Treatment (SEALANT) studyWanakorn Rattanawong, Akarin Hiransuthikul, Prakit Anukoolwittaya, et al.
Cephalalgia : an International Journal of Headache|October 21, 2022
Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster HeadacheJean Schoenen, Agneta Henriette Snoer, Roemer B Brandt, et al.
Pageof 44